A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The purpose of this study is to evaluate the safety and efficacy of NIC5-15 in the treatment of Alzheimer\'s Disease.
Epistemonikos ID: f28b27af3bf0d0a4a4a65c7c45d702e788e44f71
First added on: May 11, 2024